Loading
Latest filing published 07 Dec 2015 for Midatech Pharma US Inc..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Timothy James Heady is a declared insider of Midatech Pharma US Inc., with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 23 May 2013 to 4 December 2015.
On the market, this insider has only ever bought: 1 purchase, €5,783 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 7 December 2015, reports a transaction in Midatech Pharma US Inc. The last insider purchase was made public on 24 May 2013, 4,901 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations